China
Africa
Explore chapters and articles related to this topic
Gestational Weight Gain and Postpartum Obesity
Published in Priyanka Bhatt, Maryam Sadat Miraghajani, Sarvadaman Pathak, Yashwant Pathak, Nutraceuticals for Prenatal, Maternal and Offspring’s Nutritional Health, 2019
Obesity is defined according to the Obesity Medicine Association as a “chronic, relapsing, multifactorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical, and psychosocial health consequences.” The Body Mass Index, as mentioned earlier in the chapter, is often used by the Centers for Disease Control and Prevention and the World Health Organization to categorize weight and, according to this measurement, obesity can be classified in three different categories: Class I, Class II, and Class III, with Class III being the most severe. Another accurate method to assess the amount of adipose tissue in the human body uses dual-energy X-ray absorptiometry (DEXA) scanning. If the percentage of body fat is greater than 25% in males and greater than 32% in females, they fall in the obese category. [37]
Pharmacological Management of the Patient with Obesity
Published in James M. Rippe, Lifestyle Medicine, 2019
Magdalena Pasarica, Nikhil V. Dhurandhar
As most patients want to either lose weight or maintain their weight,7 and obesity is associated with multiple comorbidities from various specialties, it seems that all providers should be prepared to treat patients with obesity. In some cases for which pharmacotherapy is indicated, they will need to prescribe, monitor and optimize the treatment with weight loss drugs. A lot of progress has been made in this direction. First, obesity was declared a disease (http://www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf), which should increase the number of insurance companies covering obesity management with reimbursement of providers time and reasonable co-pays for patients. Second, an obesity medicine certification has been developed and is available for any provider to complete in order to become an expert in clinical management of obesity (http://abom.org/). Third, obesity medicine competencies have been developed in order to target objectives for educational activities as well as assessment activities (https://bipartisanpolicy.org/library/provider-competencies-for-the-prevention-and-management-of-obesity/). Last, but not least, the obesity management guidelines have been revised and updated with the new available drugs and other management therapies available.9,10
Medical treatment of pediatric overweight and obesity
Published in G. Michael Steelman, Eric C. Westman, Obesity, 2016
Some experts consider those children above the 95th percentile as “obese,” corresponding to a BMI of 30 (considered obese in adults) (3) (Table 11.1). The use of percentage of body weight that is fat mass is also a good marker of obesity. Using the body fat percentage, boys over 25% fat and girls over 32% fat are considered obese. Body fat percentage can be measured in the office, and obesity medicine specialists often have access to equipment that provides a measurement of percentage of body fat.
Engagement between patients with obesity and osteoarthritis and primary care physicians: a cross-sectional survey
Published in Postgraduate Medicine, 2021
Deborah B. Horn, Christopher Damsgaard, Kathi Earles, Sheba Mathew, Amanda E. Nelson
PCPs reported prescribing anti-obesity medications to an average of 21% of their patients with OA and obesity. More than half of PCPs utilize technology to help manage their patients with OA and obesity including online patient portals (54%), activity tracking apps or devices (67%), and food tracking apps or devices (68%). On average, PCPs reported referring a small proportion of their patients with OA and obesity to bariatric surgeons (10%), obesity medicine specialists (11%), registered dietitians (17%), or nutritionists (25%). Patients were typically referred when significant weight loss is required to have joint replacement surgery. These treatment referrals were to bariatric surgeons (73%), obesity medicine specialists (63%), dietitians (80%), and nutritionists(74%). Lack of patient motivation and compliance was ranked by PCPs as the greatest barrier to the treatment and management of obesity in their patients with OA; only one-quarter ranked lack of time during patient visits as the top barrier.
Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study
Published in Postgraduate Medicine, 2019
Michelle Look, Ronette L. Kolotkin, Nikhil V Dhurandhar, Joseph Nadglowski, Boris Stevenin, Angela Golden
Although clinical guidelines developed by various professional organizations including the American Heart Association (AHA), American College of Cardiology (ACC), and The Obesity Society (TOS) [23], the American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE/ACE) [24] and the Obesity Medicine Association (OMA) [25], describe strategies for identifying and treating patients with obesity, many health care providers are not well-versed in the recommendations [26]. These guidelines include several steps in obesity management, summarized as: (1) identifying patients for obesity management by screening for BMI, comorbid conditions, and complications of obesity; (2) communicating the benefits of treating obesity through weight loss including the value of sustained weight loss of 5–10%; (3) providing dietary therapy for weight loss with a plan based on the patient’s preferences and health status; (4) providing lifestyle and behavioral counseling, preferably comprehensive weight loss interventions utilizing motivational interviewing; and (5) recommending pharmacotherapy and/or bariatric surgery for patients who meet appropriate BMI and/or comorbidity criteria. To effectively manage obesity, the treatment guidelines should be combined with the communication elements from the chronic disease management models, and broaching the topic of obesity is a critical first step [27]. The 2015 Milan Declaration can provide additional guidance on how to specifically consider the patient’s perspective in addressing obesity and its management [28].
Operator-specific outcomes in endoscopic sleeve gastroplasty: a propensity-matched analysis of the US population using a multicenter database
Published in Baylor University Medical Center Proceedings, 2023
Hassam Ali, Faisal Inayat, Talia F. Malik, Pratik Patel, Gul Nawaz, Sobaan Taj, Attiq Ur Rehman, Arslan Afzal, Rizwan Ishtiaq, Muhammad Sohaib Afzal, Rashmi Advani, Rabindra R. Watson
Certification from the American Board of Obesity Medicine (ABOM), while not yet a requirement, is gradually becoming an expectation for those performing endoscopic bariatrics in light of recent advancements in the field. The acquisition of this certification demonstrates a practitioner’s commitment to maintaining the highest standards in obesity medicine and endoscopic bariatric procedures, reflecting a broader trend toward professionalization and standardization within the field. The rising importance of ABOM certification is symptomatic of the increasing complexity of obesity management in contemporary healthcare settings. It underscores the need for specialist knowledge and skills in endoscopic bariatrics.